Skip to content
Lower risk Drug recall · FDA · Published February 17, 2021

Edge Methacholine Test Kits Recall: Incorrect Storage Temperature Risk

Edge Pharma recalls methacholine challenge test kits due to incorrect storage temperature labels. This could lead to improper storage and potential product issues. Learn what to do.

🇺🇸 FDA recall #D-0306-2021DrugEdge ›
Take action

Contact the company

Recalling firmEdge Pharma, LLC856 Hercules Dr · Colchester, VT 05446-8014
✎ GovInfoNow plain-language explainer

Edge Pharma is recalling methacholine challenge test kits because the storage instructions are wrong. The kits should be kept in the refrigerator (2-8°C) but are labeled for room temperature (15-25°C). This could cause the product to degrade or become unsafe if stored incorrectly. Read more at govinfonow.com/recall/36511-edge-methacholine-test-kits-recall-incorrect-storage-temperature-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/36511-edge-methacholine-test-kits-recall-incorrect-storage-temperature-risk · Updated October 4, 2026 · FDA enforcement record: FDA #D-0306-2021

Cite this page

“Edge Methacholine Test Kits Recall: Incorrect Storage Temperature Risk.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36511-edge-methacholine-test-kits-recall-incorrect-storage-temperature-risk. Based on FDA recall #D-0306-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0306-2021%22&limit=1).

Edge Pharma, LLC voluntarily recalled Methacholine Challenge 5-Syringe Test Kits on Feb. 17, 2021, after the FDA announced the products were labeled with incorrect room temperature storage conditions instead of required refrigerated temperatures. The recall affects 213 kits distributed nationwide.

How to tell if you have it

  • Brand: Edge
  • Product: Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe
  • NDC #: 05446-1600-05
  • Lot # 12-2020-16@10, BUD 3-30-21
  • Lot # 11-2020-18@11, BUD 3-02-21

The hazard

The kits were labeled with incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions, constituting a temperature abuse hazard.

Context

GovInfoNow's records show Edge Pharma, LLC has 6 other recalls on record since March 19, 2020. Other recent recalls of similar products include McKesson Gemcitabine Injection Recall (June 10, 2026), McKesson Recalls UDENYCA Injection Due to Temperature Abuse Risk (Jan. 16, 2026), and Safecor Health Fluphenazine Elixir Recall (Aug. 13, 2026).

How to tell if you have this one

Check for Edge Pharma test kits labeled 'Methacholine Challenge 5-Syringe Test Kits, Sterile Inhalation Solution, Preservative Free, 3 mL per syringe'. Look for lot numbers 12-2020-16@10 (BUD 3-30-21) or 11-2020-18@11 (BUD 3-02-21).

  • Brand
    Edge
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Storage Conditions

    Ensure the test kits are stored in the refrigerator (2-8°C) rather than at room temperature (15-25°C).

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 4 months after the firm started it.

1. Firm started the recall: Feb 17, 202112. FDA classified it Class III: Mar 18, 202123. Published in FDA’s Enforcement Report: Mar 24, 202134. FDA terminated the recall: Jun 10, 202142021
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0306-2021 (February 17, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0306-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA